指南与共识抗菌药物管理药物不良反应与药物警戒

健康系统药学绩效指标:药学责任措施工作组更新推荐

Performance measures for health-system pharmacy: Updated recommendations from the Pharmacy Accountability Measures Work Group.
指南 / 共识 · Am J Health Syst Pharm · 2025-01-01

药学责任措施(PAM)工作组从CMS指标库中筛选绩效指标,经分析、专家评分与工作组评估,最终确定31项措施,覆盖7个治疗类别,供药学部门承担问责并推动质量改进。

要点

  • PAM工作组最终纳入31项绩效措施供药学部门问责使用。
  • 措施覆盖抗菌药物管理、行为健康、心血管病等7个治疗类别。
  • 鼓励药学领导者审阅措施并用于监测和展示药学服务价值。

核心结论

  • PAM工作组最终确定31项绩效措施,供药学部门承担问责并推动质量改进。

研究设计与样本

  • PAM工作组查询CMS指标清单工具(CMIT),经分析初筛出2256项措施,按7个预设治疗类别匹配后剩余627项,由主题专家(SME)小组按预定评分系统分析,高分措施(n=71)经SME排序并由PAM工作组进一步评估以确保符合特定标准,最终纳入31项措施。

主要发现

  • 初筛获得2256项措施,按7个预设治疗类别匹配后剩余627项,SME评分后高分措施为71项,最终纳入31项措施。

关键数值与推荐

  • 最终PAM清单纳入31项措施,覆盖7个预设治疗类别:抗菌药物管理/感染病、行为健康、心血管病、血糖控制/糖尿病、肿瘤、疼痛管理与姑息治疗、多重用药/综合用药审查/药物治疗管理。

临床怎么用

  • 健康系统药学领导者应审阅这些措施,探索领导质量改进工作的机会以优化所在机构的诊疗,并考虑如何用这些措施监测和展示药学服务的价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Performance measures identify gaps where healthcare may be improved. Pharmacists can lead organizational improvements by taking accountability for patient care and organizational improvements in the form of targeted performance measures related to medication use and care delivery. The objective of the Pharmacy Accountability Measures (PAM) Work Group is to identify a key set of measures for which pharmacy departments may assume accountability. SUMMARY: The Centers for Medicare and Medicaid Services (CMS) Measure Inventory Tool (CMIT) was queried to identify performance measures. Analyses resulted in the isolation of 2,256 measures for initial review. Measures were matched with one of 7 preidentified therapeutic categories (antimicrobial stewardship/infectious diseases, behavioral health, cardiovascular disease, glycemic control/diabetes, oncology, pain management and palliative care, and polypharmacy/comprehensive medication review/medication therapy management), resulting in a 627 remaining measures. Subject matter expert (SME) panels analyzed the measures according to a predetermined scoring system developed by the PAM Work Group. High-scoring measures (n = 71) were then ranked by the SMEs and further evaluated by the PAM Work Group to ensure specific criteria were met. A total of 31 measures were included in the final PAM listing. CONCLUSION: The shift towards value-based healthcare continues to progress. Health-system pharmacy leaders are encouraged to review these measures and explore opportunities to lead quality improvement efforts to optimize care at their respective organizations and to consider how these measures can be used to monitor and demonstrate the value of pharmacy services.

来源:Am J Health Syst Pharm,查看原文。版权归原作者所有。

引用

  1. Riddle S, Collins CD, Mahan CE, et al. Performance measures for health-system pharmacy: Updated recommendations from the Pharmacy Accountability Measures Work Group. Am J Health Syst Pharm. 2025. PMID: 40557713. doi:10.1093/ajhp/zxaf095

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。